Speciale COVID-19

Cosa sapere

Back Release N°60/2021 COVID-19: the main monitoring data from the Situation Room

ISS, November 19th 2021 

Here are the main data that emerged from the Situation Room:
●    The weekly incidence at national level continued to increase: 98 per 100 thousand inhabitants (12/11/2021 - 18 /11/2021) versus 78 per 100 thousand inhabitants (05/10/2021 - 11/11/2021), data provided by the Ministry of Health.
●    In the period between 27 October and 9 November 2021, the average Rt calculated on symptomatic cases was equal to 1.21 (range 1.14 - 1.26), and was stable compared to the previous week and above the epidemic threshold. On the other hand, the transmissibility index based on hospitalized cases decreased slightly, but still remained above the epidemic threshold (Rt = 1.09 (1.04-1.14) as at 9/11/2021 versus Rt = 1, 14 (1.1-1.19) as at 2/11/2021).
●    Bed occupancy in intensive care units was 5.3 % (Ministry of Health daily survey as at November 18) versus 4.4% (Ministry of Health daily survey as at 11/11). Bed occupancy in medical wards at national level increased to 7.1% (daily survey by the Ministry of Health as at November 18) versus 6.1% as at 11/10.
●    All 21 Regions / Autonomous Provinces were classified as being at moderate risk. Among these, one Region has a high probability of becoming high-risk according to the Ministerial Decree of 20 April 2020.
●    11 Regions / Autonomous Provinces reported a resilience alert. None of the Regions reported multiple resilience alerts.
●    There was a strong increase in the number of new cases not associated with transmission chains (15,773 versus 11,001 the previous week), while the percentage of cases detected through contact tracing remained stable (34% versus 34% the previous week). Instead, the percentage of cases detected through the onset of symptoms decreased (45% versus 48%), and instead the percentage of cases diagnosed through screening activities increased  (21% versus 18%).
 

 


Newsroom

Press releases Special on COVID-19


ISS per COVID-19